RADNOR, Pa., June 20, 2017 /PRNewswire/ — VWR (NASDAQ: VWR), the leading global independent provider of product and service solutions to laboratory and production customers, is proud to be a sponsor of the Start-Up Stadium at the BIO International Convention for the third year in a row. Over the course of the next three days, 40 start-ups will present a 5 to 7-minute pitch to key members of the investment community, venture philanthropy groups and BIO attendees.
“Start-up organizations like these develop new technologies, discover cures and accelerate diagnosis of diseases,” stated Manuel Brocke-Benz, President and CEO of VWR. “We are proud to sponsor this event helping these organizations as well as the biotech industry as a whole.”
The BIO International Convention, the world’s largest biotechnology event, provides several specialized opportunities geared towards start-up and emerging companies. Over 100 applications were reviewed and 40 finalist selected. Representing 14 U.S. states and three additional countries – Canada, Germany, and India, these start-ups are dedicated to developing cutting-edge technologies and therapeutic solutions. This exciting interactive experience will allow investors to provide live feedback to the start-up biotech companies.
VWR supports BIO throughout the year, both locally and nationally, by providing its members with product and service solutions that help stretch their lab budgets to support the growth of these organizations as they heal, fuel and feed the world.
VWR looks forward to engaging members at the BIO International Convention. Visit the BIO Member Services Pavilion, #2925 to learn more about the BIO-VWR program.
About VWR
VWR (NASDAQ: VWR), headquartered in Radnor, Pennsylvania, is the leading global independent provider of product and service solutions to laboratory and production customers. With sales in excess of $4.5 billion in 2016, VWR enables science for customers in the pharmaceutical, biotechnology, industrial, education, government and healthcare industries. With more than 160 years of experience, VWR has cultivated a value proposition delivering product choice, operational excellence and differentiated services to improve our customers’ productivity from research to production. VWR’s differentiated services provide innovative, flexible and customized solutions from scientific research services to custom-manufactured chemical blends. Our dedicated team of more than 10,200 associates is focused on supporting scientists, medical professionals and production engineers to achieve their goals.
For more information on VWR please visit www.vwr.com.
Media Contact:
Valerie Collado
Director, Corporate Communications
VWR Corporation
Phone: +484.885.9338
valerie_collado@vwr.com
Investor Contact:
John Sweeney, CFA
VP, Investor Relations
Phone: +610.386.1483
ir@vwr.com
https://photos.prnewswire.com/prnvar/20101109/NY97837LOGO
SOURCE VWR